Clinical Trial Update: Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP)

View source ↗

Summary

A clinical trial update detailing observations from patients with non-small cell lung cancer who achieved long-term responses in the Gefitinib (Iressa) Expanded…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Iressa (gefitinib)

Snippet

Sponsor: AstraZeneca | Conditions: Non-Small Cell Lung Cancer | Status: COMPLETED